GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CROSSJECT (XPAR:ALCJ) » Definitions » Current Accrued Expense

CROSSJECT (XPAR:ALCJ) Current Accrued Expense : €0.00 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is CROSSJECT Current Accrued Expense?

CROSSJECT's Current Accrued Expense for the quarter that ended in Dec. 2023 was €0.00 Mil.


CROSSJECT Current Accrued Expense Historical Data

The historical data trend for CROSSJECT's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CROSSJECT Current Accrued Expense Chart

CROSSJECT Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CROSSJECT Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CROSSJECT Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


CROSSJECT Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of CROSSJECT's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CROSSJECT Business Description

Traded in Other Exchanges
Address
60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.

CROSSJECT Headlines

No Headlines